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Why emergency management 
should be interested in the 
emergence of antibiotic resistance 
Associate Professor Dale Dominey-Howes, Dr Carolyn Michael and  
Dr Maurizio Labbate explain why the emergence of antibiotic resistance 
should be rebranded as a disaster risk management problem.
A version of this paper was presented at the Australian & New Zealand Disaster and Emergency Management Conference in May 2014.
ABSTRACT
Bacterial epidemics and pandemics are 
biological risks to life every bit as significant 
as floods, fires, storms and earthquakes. 
Antibiotics have been a significant tool in the 
management of epidemics and pandemics 
(as well as for fighting general infections) 
since their discovery in the 1930s. Due to 
the development of antibiotic resistance by 
bacteria, we are now approaching a post-
antibiotic era where our capacity to manage 
infectious disease, particularly bacterial 
epidemics and pandemics, is compromised. 
Despite considerable efforts by global heath 
organisations, we need new ways of thinking and 
acting on the global risk of antibiotic resistance. 
We argue for a rebranding of the issue to one 
of a disaster risk and suggest the use of the 
risk management process and expertise of 
emergency management to present a new way 
of thinking about this globally significant risk 
to life.
Introduction 
Disasters take lives, cause devastation, impact 
individuals, families and communities and disrupt our 
socio-economic systems (Adger, et al. 2005). Infectious 
disease resulting in epidemics and pandemics 
represent a disaster risk to life every bit as significant 
as fire, flood, storm and other common, high profile 
disasters. Emergency management agencies under 
the structure of emergency management and response 
plans, prepare for, and respond to, sudden and slow 
onset disasters using an ‘all hazards approach’ and the 
emergency risk management process. For example, in 
New South Wales, epidemic and pandemic emergency 
management arrangements fall to the NSW Ministry 
of Health via the State Emergency Management Plan 
(EMPLAN).
Before the 1930s, bacterial infections caused 
significant morbidity and mortality. Historically, 
bacteria have been responsible for epidemics and 
pandemics including the Black Death and Tuberculosis. 
Antibiotics have saved countless lives, revolutionised 
medical care (by allowing invasive medical procedures 
otherwise associated with a high risk of bacterial 
infection Gottlieb & Nimmo 2011), and provided a 
powerful tool to aid in the fight of bacterial epidemics 
and pandemics. However, bacteria have become 
resistant to antibiotics and we are reaching a ‘post-
antibiotic era’ where bacterial infections will be 
difficult, if not impossible to treat (Prasad & Smith 
2013, CDC 2013, WHO 2012). 
As a slow onset disaster, antibiotic resistant infections 
are rising and already affect millions of people 
globally (WHO 2012). Sudden onset antibiotic resistant 
outbreaks regularly occur in hospitals, affecting the 
most vulnerable and require costly interventions. In 
the United States for example, over two million people 
are affected by antibiotic resistant infections with at 
least 23 000 deaths annually. This equals US$20 billion 
in extra healthcare costs and US$35 billion in lost 
productivity (CDC 2013). Such statistics have led to 
calls to urgently address this problem coming from, 
among others, the World Health Organization (WHO) 
and the Center for Disease Control (CDC) (CDC 2013, 
WHO 2012) and from respected individuals such as the 
UK Chief Medical Officer, Professor Dame Sally Davies 
(Walsh 2013) and the Chief Australian Scientist (Prasad 
& Smith 2013). They have also become increasingly 
urgent with Professor Dame Sally Davies calling for 
antibiotic resistance to be placed on the risk register 
ahead of terrorism (Walsh 2013). 
For sudden onset bacterial epidemics and pandemics, 
antibiotics are one of the major management tools. 
The emergence of antibiotic resistance means 
that the capacity of health systems to manage the 
associated disaster risk is more complicated. The risk 
is heightened by poor community awareness of the 
problem of antibiotic resistance (Francis, et al. 2012). 
How the antibiotic resistance 
problem has developed
Bacteria, among the oldest forms of life, are mostly 
harmless to humans and are essential for a healthy 
environment (e.g. nutrient cycling) and body (e.g. 
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production of vitamins). Only a minority are pathogenic 
and, so, deleterious to humans. Bacteria are 
remarkably resilient and adaptable and have managed 
to occupy almost every ecological niche overcoming 
all manner of environmental challenges. Thus, as 
foretold by the discoverer of Penicillin, Alexander 
Fleming, resistance to antibiotics was always a given. 
Particularly striking is the rate at which bacteria have 
evolved antibiotic resistance. In just 70 years since 
the first use of Penicillin, some bacterial infections 
are no longer treatable (CDC 2013, WHO 2012). In this 
context, humanity is largely to blame. Much has been 
said about the reasons for the resistance problem 
(CDC 2013, WHO 2012) which is highly complex. 
However, in its most basic form, antibiotic use leads to 
antibiotic resistance. 
Widespread use, overuse and misuse of antibiotics in 
multiple settings including medicine, agriculture, and 
animal husbandry to prevent infection (i.e. prophylaxis), 
or as a method of promoting increased animal growth, 
has created strong selective pressures in favour of 
bacteria that resist antibiotics. Consequently, resistant 
bacteria are found increasingly on and in humans, 
farm animals, seafood, fruit and vegetables and in 
the environment (Baquero, Mrtinez & Cantón 2008, 
Kemper 2008, Wright 2010). Bacteria acquire antibiotic 
resistance in two ways. The first is by genetic mutation. 
The second is by actually passing genetic material 
containing genes that provide resistance between 
bacteria — a process called horizontal gene transfer 
(HGT). The consumption of food or direct contact 
with people or environments containing antibiotic 
resistant bacteria can cause normal healthy bacteria 
in and on humans to acquire resistance via HGT. This 
acquired resistance may then spread through human 
communities and may be passed on to disease-causing 
bacteria during an infection. Once resistance has been 
acquired by a pathogenic bacterium it is maintained by 
the continued pressure of antibiotic use, as observed by 
the levels of resistance in hospitals where antibiotics 
are commonly used. Through antibiotic use, overuse 
and misuse, we have added unnecessary fuel to the fire 
of antibiotic resistance and decreased the shelf life of 
these important drugs. 
Antibiotics are among the most commonly prescribed 
drugs in human medicine and it is estimated that up 
to 50 per cent of all the antibiotics prescribed are 
unnecessarily or ineffectively prescribed (CDC 2013). In 
Australia, 22 million scripts are written for antibiotics 
each year. It is extremely likely that a significant 
number are unnecessary due to inappropriate 
prescription for, among other reasons, viral infections 
— a distinction not often understood by the public, 
health practitioners and the media. In fact, a National 
Prescribing survey found 62 per cent of patients 
did not know that overusing antibiotics increased 
resistance (NPSMW 2013). To date, resistance to one 
antibiotic was circumvented by the development of new 
antibiotics. However, following the development of each 
new antibiotic, bacteria have evolved or acquired new 
resistance capability. Unfortunately, we can no longer 
rely on the development of new antibiotics because 
their pharmaceutical development has stalled due 
to economic and regulatory reasons (Power 2006). 
Drug discovery and development is expensive and it 
is estimated that ~US$1 billion is spent before a drug 
reaches the market (Power 2006). Given the speed at 
which bacteria become resistant, a pharmaceutical 
company may only achieve circa five years of revenue 
before drug effectiveness begins to diminish. 
Furthermore, courses of treatment are short (typically 
one week) so the capacity to generate profit is modest. 
Consequently, society is left with a situation where the 
current suite of antibiotics is losing its effectiveness 
and there is a dearth of new antibiotics coming onto 
the market. Unless something changes quickly, the 
post-antibiotic era of untreatable bacterial infections, 
including epidemics and pandemics, is inevitable.
Addressing the antibiotic resistance 
problem
The problem of antibiotic resistance has not 
been ignored and expert panels in consultation 
with governments have made recommendations 
for reducing the burden of antibiotic resistance. 
In the most recent WHO report (WHO 2012), 
recommendations included:
1. Preventing bacterial infections and the spread 
of antibiotic resistance: Implementation of good 
hygienic practices is effective in controlling the 
spread of bacterial infections. Regular hand 
washing can prevent infections being spread. 
Furthermore, isolation of hospital patients infected 
with or detected as carrying resistant bacteria is 
advised.
2. Surveillance of antibiotics and antibiotic 
resistance: Through effective surveillance of 
antibiotic use and antibiotic resistance, policies 
and actions may be developed and implemented 
to control antibiotic use and contain resistance 
outbreaks. Surveillance of antibiotic resistance 
can guide prescription in life-and-death medical 
situations to ensure appropriate selection of an 
effective antibiotic.
3. Antibiotic stewardship: Proper administration of 
antibiotics by heath practitioners would reduce 
the selection pressure on bacteria and reduce 
the emergence of resistance. This includes not 
using antibiotics when they are not effective and 
selecting the most appropriate antibiotic for specific 
infections. Part of the solution is better education 
of the problem so that appropriate behaviour 
regarding the use of antibiotics is encouraged.
4. Reduce use of antibiotics in agriculture: The use 
of antibiotics for growth promotion in animals 
adds unnecessary pressure. As a source of human 
food, there is direct contact between humans and 
antibiotics and antibiotic resistant bacteria that 
facilitates the spread. Even more concerning is that 
resistant human pathogens are commonly found on 
food animals. Some countries have banned the use 
of antibiotics in agriculture but the use is still widely 
practiced.
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5. Development of new antibiotics, vaccines 
and other treatments: More investment from 
governments into research and development 
and greater incentive for industry to invest in the 
development of new antibiotics and vaccines is 
required. 
6. Development of improved diagnostic tests of 
bacterial infections: To assist improved antibiotic 
stewardship and surveillance, cheaper and 
more rapid methods to identify specific bacterial 
infections and detecting antibiotic resistance are 
required.
Many of these recommendations have been 
implemented globally. However, their effectiveness 
is dependent on their enforcement and whether 
resources are available to implement them. With the 
declining effectiveness of antibiotics there is a future 
risk that control of bacterial infectious outbreaks 
will be troublesome. Already we are seeing hospitals 
regularly dealing with outbreaks of superbugs 
requiring ring-fencing of vulnerable patients (barrier 
nursing), increased cleaning procedures, and increased 
surveillance of superbugs on patients, hospital staff 
and the hospital environment. Hospital-acquired 
(nosocomial) infections, most of which are multi-drug 
resistant, affect 5-10 per cent of hospital patients 
costing in excess of AU$2-3 billion (Gilbert, Iredelle & 
Merlino 2014). At the moment, the vulnerable are at 
most risk of untreatable nosocomial infections because 
of compromised immune systems and being exposed 
to invasive medical techniques such as surgery and 
catheter use that facilitate direct access of bacteria to 
the bloodstream. 
It seems unlikely that the recommendations previously 
listed will stem the flow of the emergence of antibiotic 
resistance. However, it is clear that dealing with the 
problem is complex and requires a multi-pronged 
approach that involves consultation and co-operation 
among stakeholders. 
Rebranding antibiotic resistance as a 
disaster risk management problem
To date, responsibility for responding to the slow onset 
risk of antibiotic resistance has fallen to the health and 
medical industries. Globally, health authorities and 
practitioners have done a tremendous job. But, given 
the scale of the looming crisis, the time has come 
for other experts to join the fight. Since slow onset 
antibiotic resistance forms the foundation and trigger 
for an inevitable rapid onset epidemic or pandemic, 
the use of the emergency risk management process 
provides a novel way of thinking about responding 
to the risk now. It provides a useful foundation to 
engage with the public and others on preparing 
for and managing the disaster risk of antibiotic 
resistant bacterial infections generally, and bacterial 
epidemics and pandemics specifically. The public 
is, in a sense, already primed to the value of risk 
management. By analogy, if hundreds or thousands 
of people were dying each year in bushfires, floods, 
storms or tropical cyclones, this would be considered 
a very serious ‘disaster risk management problem’. 
Bacteria are biological risks to life and as such, they 
fall within the context of risk management. Given 
that many thousands of people are dying each year 
due to the acquisition of antibiotic resistant bacterial 
infections, the implications for the field of disaster 
risk management become obvious. This is without 
consideration of the occurrence of antibiotic resistant 
bacterial epidemics and pandemics. As such the 
potential for this approach to be understood by the 
public is high. 
We propose that the issue of antibiotic resistance be 
rebranded as a disaster risk management problem and 
that the emergency risk management process be 
adopted in order to provide new ideas and innovations 
to address the problem. The emergency risk 
management process (Figure 1) is described in AS/NZS 
ISO 31000:2009. The process should be integral to 
management and decision-making, integrated into 
practices and culture, and tailored to communities and 
their risk profiles. In an emergency management 
context, risk management is a process that involves 
dealing with risks arising from emergency events (such 
as the occurrence of bacterial epidemics and 
pandemics). It is a systematic method for identifying, 
analysing, evaluating, and treating emergency risks and 
takes an iterative approach with well-defined activities, 
leading to implementation of effective risk-treatment 
strategies. In the case of antibiotic resistance, 
mitigation measures for sudden onset antibiotic 
resistant epidemics and pandemics identified by the 
framework complements measures already 
implemented by medical health authorities for slow 
onset antibiotic resistance infections generally.
The process comprises five elements: 
• establishing the context
• identifying the risks
• analysing the risks
• evaluating the risks, and
• treating the risks.
These elements are supported by enabling activities 
of communicating and consulting, and monitoring and 
reviewing, which apply to each of the major elements 
of the process. Risk assessment (the yellow part of 
Figure 1) also comprises the identification, analysis 
and evaluation of risk elements of the emergency 
risk management process. This is important to 
understand, together with the idea of ‘communication 
and consultation’ with stakeholders, because high 
community perceptions and awareness of risk to life 
is one of the central tenants of effective disaster risk 
reduction (Bird 2009, Hoppner et al. 2012). 
Image taken from the Australian Government Report in National Emergency Risk Assessment Guidelines (Government 2010 p. 13).
Figure 1: The emergency risk management process used by governments worldwide. 
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In relation to the emergence of antibiotic resistance 
and its effect on the risk profile of epidemic and 
pandemic infections, poor community risk perception 
is thought to lead to inappropriate behaviours such 
as patients demanding antibiotics for viral infections 
or patients failing to complete a course of antibiotics. 
Given the significance afforded the problem by global 
organisations like the CDC and the WHO, it is curious 
that the issue of antibiotic resistance seems so little 
understood, or of such low concern, to the public 
generally. This continues despite Option 3 (Antibiotic 
stewardship) by the WHO (and repeated by others) 
of engaging with the community through education 
programs to raise awareness of the issue. 
Poor community risk perception is well known in the 
wider disaster risk reduction literature for influencing 
appropriate and inappropriate risk behaviour. 
Significantly, we do not have a comprehensive 
understanding of how communities perceive antibiotics, 
their use, and the problem of antibiotic resistance 
generally. A thorough understanding of these factors is 
necessary to guide education programs and strategies 
that reduce risk and increase community resilience. 
Consequently, we are missing a significant element of 
the data required to assess the risk as detailed in the 
emergency risk management process. Addressing the 
problem of why communities have poor risk perception 
is easily investigated and one of the simplest 
challenges to address. Risk managers have a critical 
and useful role to play. Risk managers can help as 
they are experienced in investigating why communities 
behave the way they do, hold the views and perceptions 
of risks they do, and can communicate complex risk 
information to the public.
Where to from here
Modification of community behaviour is probably 
the cheapest and most effective way of dealing with 
the issue of antibiotic resistance and managing the 
associated risk. An understanding of the barriers that 
are preventing appropriate decision-making in the 
request and prescription of antibiotics is necessary 
for designing targeted and effective education 
campaigns to the community and health practitioners. 
Consequently, in order to address this issue and shift 
the public discourse to one of increased community 
engagement and awareness, a rebranding of the issue 
Image taken from the Australian Government Report in National Emergency Risk Assessment Guidelines (Government 2010 p. 13).
Figure 1: The emergency risk management process used by governments worldwide. 
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away from one of ‘general health and medicine’ to 
one of ‘disaster risk reduction’ would be helpful and 
represents a novel approach not yet considered. It is 
our opinion that the emergence of antibiotic resistance 
is in fact, a risk that ought to be framed as a disaster 
risk management problem. Consequently, we make an 
urgent and novel call for the emergency management 
community and socio-behavioural experts in risk 
perception to recognise the threat that the emergence 
of antibiotic resistant bacterial infections represents 
generally, and antibiotic resistant bacterial epidemics 
and pandemics specifically. It is our profound view 
that such an approach would deliver multiple benefits 
including:
• increased community understanding and awareness 
of the profound risk to health and life of the 
emergence of antibiotic resistance generally and 
the implications for the occurrence of antibiotic 
resistant bacterial epidemic and pandemic infections 
specifically
• improved individual and community behaviour (risk 
management/adaptation) in relation to the risk 
leading to a reduction in the selection pressure 
driving the emergence of antibiotic resistance
• enhanced skills and capacity of the health service 
professionals to treat and support communities 
facing antibiotic resistant infections, especially 
epidemics and pandemics
• improved emergency management capacity to 
anticipate and cope with the risk of antibiotic 
resistant epidemics and pandemics as well as the 
emergence of resistant infections in the community, 
and
• reduced death, suffering, loss and burden of 
disease.
We strongly urge the emergency management 
community and risk researchers to join the fight before 
it is too late – before an antibiotic resistant bacterial 
epidemic or pandemic strikes.
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